
A leading cancer charity has warned that a number of key drugs are at risk of being withdrawn from patients …

UK scientists have used a laser beam trap to examine how drug particles from asthma inhalers travel through the air …

GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …

VorroHealth the healthcare clinical tech provider firm has appointed Maria Moen to the newly-created position of vice president of Care Innovation. Moen …
UK biotech Horizon Discovery has formed a new Scientific Advisory Board (SAB) for its diagnostics arm to recommend better cancer …

Medical devices and imaging technology have been included in a recent analysis of the top 50 most innovative technologies. Frost …

Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …

A much-lauded project to reduce unnecessary hospital visits and shift care into the community will fall well short of its …
Doctors’ leaders are demanding greater investment in out-of-hours GP services, warning of ‘fragmentation’ and underfunding, and branding the current system …

Contract research organisation Theorem has named Kathryn Bohannon as vice president of its biopharma development unit, and Angela Weston as …

Eisai has lashed out at a major German health assessment body, calling its stance on first-in-class epilepsy treatment Fycompa ‘deeply …

The US FDA has finalised the details of its registration scheme for pharma manufacturing facilities, which aims to make it …

General practitioners in the UK are to begin ‘prescribing’ health apps as part of a move to better monitor issues …

The Scottish Medicines Consortium (SMC) has shown AstraZeneca’s Onglyza (saxagliptin) the green light to be used with insulin in patients …

Life sciences services company inVentiv Health has announced the appointment of Jeffrey Wilks as the president of its advertising businesses. …

UCB is to sell its US generics business Kremers Urban to two private equity firms in a $1.5 billion deal. …

Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …

Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …

How did you find your way into your current role? After completing an MSc in Economics at the London School …

Californian medical device firm myoscience has appointed Jeffrey Gold as its chief executive. Gold who was the president and chief …